Regulatory
Supreme Court Mulls Testimony About AERs in Zicam Case
January 12th 2011Should drug and supplement companies be required to alert investors whenever any adverse-event report (AERs) over a product arises-in case an AER is predictive of a larger problem with the product that could devalue shareholder stocks?
NPA Invites Industry Members to Lobby New Congress
December 13th 2010The dietary supplements industry will have the valuable opportunity to meet with member of Congress, especially new members, during the Natural Products Association’s (NPA; Washington, DC) 14th annual Natural Products Day on Wednesday, April 6.
Tablets and Capsules: Stricter Standards for Excipients?
December 1st 2010Excipients might not always be the star of a dietary supplement product-that role most likely goes to the active ingredient-but make no mistake that excipients are more than just “filler.” And, excipients will need to answer to stricter FDA regulation in the near future, according to David Schoneker, director of global regulatory affairs for Colorcon (Harleysville, PA) and past chairman of the International Pharamceutical Excipients Council (IPEC). Schoneker spoke at a recent webcast sponsored by the Council for Responsible Nutrition and Virgo Publishing.